Wolverine Trading
SCMP

Wolverine Trading’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Wolverine Trading’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-31,900
Closed -$573K – 6307
2017
Q4 		$573K Buy
+31,900
New +$393K ﹤0.01% 2837
2017
Q3 		– Sell
-32,600
Closed -$346K – 5481
2017
Q2 		$346K Buy
+32,600
New +$332K ﹤0.01% 2828

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Wolverine Trading's SCMP Position: Q1 2018 in Review

Wolverine Trading sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,889 shares — an estimated $393K sold.

Wolverine Trading first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $393K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Wolverine Trading reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Wolverine Trading sold 21,889 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $393K.
  • Wolverine Trading first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Wolverine Trading's Sucampo Pharmaceuticals, Inc. position peaked at $393K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Wolverine Trading's 13F filing for Q1 2018, filed 15 May 2018.